A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of the Effects of K201 Injection, 2 mg/mL on the Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2012
At a glance
- Drugs JTV 519 (Primary) ; JTV 519 (Primary)
- Indications Atrial fibrillation
- Focus Pharmacodynamics
- Acronyms RESTORATION
- Sponsors Sequel Pharmaceuticals
- 13 Jan 2010 Actual patient number (153) added as reported by ClinicalTrials.gov.
- 13 Jan 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov.
- 13 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.